Jefferies reiterates Howmet Aerospace stock rating after analyst day By Investing.com

Howmet Aerospace is pursuing a ~$1.8B cash acquisition of Consolidated Aerospace Manufacturing financed by a $1.2B note offering ($400M due 2028, $300M due 2029, $500M due 2036); the deal is expected to close soon pending approvals. Jefferies reiterated a Buy with a $315 PT and UBS raised its PT to $260; the stock is up 108% over the past year to $253.91 and trades at a P/E of 68.66. Management declared a $0.12 quarterly dividend payable Feb 2026, while Consolidated is forecast to generate $485–495M revenue in FY2026 with adjusted EBITDA margins >20% (pre-synergies). Eleven analysts have revised earnings estimates higher, supporting a bullish outlook driven by automation, new engine introductions in 2026, and potential margin expansion.

Analysis

The market is pricing Howmet as a growth story with a large operational lift already embedded; the trade/valuation hinges more on execution of integration, NPI cadence, and manufacturing yield improvement than on cyclical end-market recovery. A debt-funded strategic bolt-on increases execution risk: if certification or ramp timelines slip by even a quarter, working capital and interest costs will compress free cash flow and re-rate growth multiple very quickly. Supply-chain winners are likely to be automation and digital-manufacturing vendors (machine-tool OEMs, inspection/vision systems, MES software) as Howmet pursues yield and throughput gains; conversely, smaller precision-casters/finishers who sell to the same OEMs face pricing pressure and potential contract loss. Near-term catalysts that will move the stock materially are close of the deal, first combined-quarter guidance, and the 2026 engine NPI cadence; each contains binary outcomes that can swing equity +/-20–30% inside 3–12 months.

Key Decisions for Investors

• Directional, defined-risk long HWM: Buy HWM Jan 2027 260/360 call spread (debit). Rationale: captures upside from integration and NPI realization with capped downside = premium; target 40–80% return if combined EBITDA accretion shows through in 2026 guidance; exit/hedge if combined revenue misses guide by >5% or if integration disclosure slips >90 days.
• Tail-hedge the long with puts: Buy HWM 9-month 200 puts (protects the position to guard against a >20% equity gap down on regulatory/intergration news). Max loss = premium; effective if interest rates or certification delays reset multiple.
• Relative-value pair: Long SWK equity (6–12 month) / short HWM equity (dollar-neutral). Rationale: SWK should mechanically derisk its balance sheet as divest proceeds are deployed while HWM carries integration/levering risk. Target asymmetric payoff of 15–25% on SWK with limited correlation bleed if HWM operational execution falters.
• Event-driven credit idea: Monitor primary demand on HWM’s note tranches post-close for dislocation; if secondary spread >[IG+250bp], consider buying HWM shorter-dated paper (2028/2029) selective for carry—reward = pick-up if synergies materialize, risk = downgrade/credit widening if integration stalls.